💰 AXON $4.5M Deep-ITM Call Sale — Smart Money Takes Chips Off the Table 🎯

📅 July 13, 2026 | 🔥 Unusual Activity Detected

✅ Updated July 14, 2026 — OI RESOLVED. The next-day OPRA open-interest snapshot is in: OI rose 262 → 530 (+268 vs. a 263-lot trade**)**, proving this was STO — sold to OPEN a new short call, not a profit-take. The closing/STC branch is ruled out. See the ✅ RESOLVED box below.

---

🎯 The Quick Take

Someone just SOLD 263 deep-in-the-money Sep 18 $420 calls on AXON for ≈$4.5M, printing right at the bid at 09:37:33 while the stock traded at $571. AXON has ripped ≈44% over the past three months and ≈34% in just the last week — this is a big winner writing calls against an existing position, not a fresh bearish bet. Next-day OI has now confirmed the order type: STO (sold to open). Open interest rose from 262 to 530 (+268 against a 263-lot trade), which means new contracts were created — so this opened a new short call, and the "cashing out an old long call" (STC) possibility is eliminated. ✅

---

📊 Company Overview

Axon Enterprise (AXON) is the dominant public-safety technology company behind the TASER conducted-energy device, body-worn and in-car cameras ("Personal Sensors"), and the Axon Evidence.com cloud-and-AI software platform:

• Market Cap: ≈$43.0 Billion
• Sector/Industry: Industrials — Aerospace & Defense / Public-Safety Technology
• Current Price: ≈$557.9 (trade printed at $571 earlier in the session), ≈37% below its 52-week high of $885.92
• Primary Business: TASER conducted-energy weapons, body/fleet cameras, real-time crime center software (Fusus), counter-drone (Dedrone), and AI products (Draft One, Axon Assistant) sold on a recurring software/hardware-as-a-service model

---

💰 The Option Flow Breakdown

The Tape (July 13, 2026 @ 09:37:33):

Flow Tag: ⚡ Lit Sale (Sold at the Bid) — this printed on the regular displayed market, not a negotiated block cross or auction. The trade landed right at the bid (0% across the bid-ask spread), which is the textbook signature of a seller hitting the bid — someone was actively getting rid of these calls, not chasing them.

✅ RESOLVED — Next-Day OI Confirms: STO (Sold to OPEN a New Short Call)

Resolved 2026-07-14 from the ≈06:30 ET OPRA open-interest snapshot. This box replaces the ⏳ provisional flag that was published on July 13.

Open interest ROSE by 268 against a trade size of 263 — an essentially exact match. New contracts had to be created to fill this order, which is the deterministic proof of an opening trade. Combined with the SELL side, the order type is now confirmed: STO — sold to open.

What this rules OUT: the profit-taking branch (STC — selling to close an existing long call) is now eliminated. If this had been a winner cashing out of a long call position, open interest would have fallen by ≈263 toward zero. It did the opposite. Nobody closed anything here.

What this confirms: a new short call position was created — a covered-call overwrite (the far more likely case: someone who owns AXON stock or deep long calls writing $420 calls against them for income) or, less likely, a naked short call. Either way this is a fresh short-upside position, not an exit.

Does this change the story? Only slightly — and honestly, in a mildly more bearish-lean direction. A profit-take (STC) is a neutral act: you had a gain, you took it, you're flat. Writing a new short call (STO) is a forward-looking statement: this desk is now actively short AXON upside above $420 through September, and they were willing to accept that cap. It is still NOT a bearish bet — selling deep-ITM calls against stock you own is income and de-risking, not a short thesis — but it is a live, ongoing position rather than a closed chapter.

🤓 What This Actually Means — Plain English

Let's decode this one, because "deep in the money" trades confuse people:

• 💵 This call is almost pure intrinsic value, barely a bet anymore. With AXON at $571 and the strike at $420, the call is worth ≈$151 just from intrinsic value (571 − 420). The option actually traded at $169.60, meaning only ≈$18.60 of "time value" (extrinsic premium) is left. In plain terms: this option behaves almost exactly like 100 shares of stock at this point, not a lottery ticket.
• 🏦 Selling a call like this usually means one of two things — and next-day OI has now told us WHICH: (1) profit-taking (STC) — someone cashing out an old long-call gain — or (2) a covered-call overwrite (STO) — someone who owns AXON shares selling calls against them to collect income and cap upside. OI rose +268, so it's (2): a covered-call overwrite. The profit-take branch is ruled out. This desk is not cashing out; they are betting AXON won't run dramatically further past $420 before September, and getting paid $4.5M to say so.
• 🚫 This is NOT an aggressive bearish short bet. Selling deep-ITM calls at the bid on a name that just ran 44% in three months reads as de-risking into strength, not "AXON is going to crash." Don't confuse "seller of calls" with "buyer of puts" — those are very different trades with very different conviction levels.
• 📉 Order type is now RESOLVED: STO. Open interest rose 262 → 530 (+268 vs. a 263-lot print), the deterministic proof of an open. Read this as "someone opened a new, live short-upside position against AXON above $420" — a cap, not a crash call, and an ongoing position rather than a closed one.
• 🧊 One clean trade, no shenanigans. Verification against the raw OPRA tape shows no cancels, no multi-leg structure, no stock-combo pairing — this was one straightforward electronic execution. The size and premium match cleanly.

Unusual Score context: A $4.5M single-print sale is a real, meaningfully-sized trade for AXON's options market — sizeable enough to register as unusual flow, though not an outlier compared to the biggest mega-cap prints. Read it as "someone with real size decided to take profit or write calls today," not a once-a-year event.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

AXON has been one of 2026's standout movers. After a period of consolidation, the stock has gone vertical over the past three months — up ≈44% in three months and ≈34% in just the last week — driven by a blowout Q1 print, a 700%+ AI-revenue surge, and a politically-charged ICE contract headline. Even after that surge, AXON at ≈$557.9 remains roughly 35-37% below its all-time/52-week high of $885.92, showing there's real room between here and the prior peak even after the recent sprint.

Key observations:

• 🚀 Parabolic short-term move: The bulk of the recent gain came in the past week alone — that kind of velocity often invites profit-taking, which is consistent with today's call sale.
• 📊 Still well off the highs: Unlike a name making fresh all-time highs, AXON has real distance (≈35%+) to its 52-week peak — this isn't a "the top is in" chart on its face.
• ⚠️ Extended near-term: A 34% move in a single week on a partly-political, not-yet-awarded headline (the ICE TASER contract) is the kind of move that tends to digest/consolidate rather than extend in a straight line.

Gamma-Based Support & Resistance Analysis

Current Price: ≈$557.56

⚠️ Important caveat first: AXON's gamma exposure is thin relative to a name like AMD or NVDA — this is a high-volatility, moderately-sized options market, so these levels should be read as directional signposts, not hard walls. Don't expect the same mechanical pinning behavior you'd see in a mega-cap with dense options open interest.

With that caveat, here's what the gamma map shows:

🔵 Support Zone (Put Gamma Below Price):

• ≈$500 — the largest concentration of put-side gamma below the current price. This is the closest thing AXON has to a structural floor in the near term (roughly 10% below spot).
• ≈$450-$510 — a scattering of smaller support pockets; none individually dominant, consistent with the "thin gamma" caveat above.

🟠 Resistance Zone (Call Gamma Above Price):

• ≈$600 — the single largest gamma concentration on the entire chain, both above and below spot. This is the clearest "magnet/ceiling" level in the data — dealers hedging this strike would be natural sellers into strength as price approaches it (roughly 7.5% above spot).
• ≈$560 — essentially sitting right on top of the current price (less than 0.5% away) — a near-term pivot rather than a real wall.
• ≈$580, $650, $700, $790 — progressively thinner resistance pockets stretching out toward year-end and beyond.

What this means for traders: The $420 strike from today's trade sits well below all of this gamma structure — it's so deep in the money that it barely registers on the gamma map anymore (deep-ITM options carry very little gamma; they behave like stock). That reinforces the profit-take/overwrite read: this trade isn't about betting on a specific gamma level, it's about monetizing existing intrinsic value. The $600 zone is the level to watch if AXON keeps running — that's where dealer positioning gets heaviest on the upside. $500 is the nearest real support pocket on a pullback.

Implied Move Analysis

Options market pricing for upcoming expirations:

• 📅 Weekly (Jul 17 — 4 days): ±7.61% (±$42.47) → Range: $515.44 - $600.38
• 📅 Quarterly Triple Witch (Sep 18 — 67 days — SAME EXPIRATION as today's trade!): ±31.44% (±$175.41) → Range: $382.50 - $733.32
• 📅 LEAPS (Jun 17, 2027 — 339 days): ±67.22% (±$375.03) → Range: $182.88 - $932.94

Translation for regular folks: The options market is pricing a fairly wild ±7.6% swing possibility just through this Friday's monthly OPEX — a reminder of how volatile this name has become. By the September 18 expiration — the exact date this $4.5M trade expires — the market is pricing a ±31.4% range ($382.50 to $733.32). Notice that the $420 strike sold today sits inside the lower third of that range, not near the edges: the options market thinks a meaningful pullback toward $420 is a real, if unlikely, possibility by September, which is a plausible reason for a holder to lock in today's intrinsic value now rather than risk giving it back.

---

🎪 Catalysts

✅ Recent Catalysts (Already Happened)

Q1 2026 Earnings Beat + Guidance Raise — May 6, 2026

Axon reported Q1 2026 revenue of $807 million, up 34% year-over-year — the ninth straight quarter of >30% growth — with net income of $169M and diluted EPS of $2.05. ARR hit $1.5B, up 35%, net revenue retention was 125%, and future contracted bookings reached $14.3B, up 44% (Axon IR). Most striking: AI product revenue was up 700% year-over-year (Investing.com Q1 slides), and Axon raised its FY2026 revenue growth guidance to 30-32% (from 27-30%).

Draft One AI Adoption + Enterprise Expansion

Axon's AI report-writing tool Draft One surpassed 1 million field uses and is expanding beyond law enforcement into healthcare (Investing.com). Its Fusus real-time crime center product anchored a $40M enterprise win with a major telecom provider (StockStory Q1 deep dive).

The Trump/ICE TASER Headline — June 29, 2026

Disclosure that President Trump bought $1-5M of AXON stock on February 10, followed weeks later by an ICE notice seeking a 5-year, $220M TASER contract (≈17,800 devices), sent AXON up ≈10.5% intraday on June 29 (CNBC; Motley Fool). Importantly, the $220M contract has not been awarded yet, and Axon's existing (much smaller, ≈$16.1M) incumbent ICE TASER deal lapses on August 21.

Analyst Upgrade — July 6, 2026

Needham raised its price target to $750 (from $600) just days before this trade printed (MarketBeat). Consensus skews heavily bullish at roughly 18 Buy / 2 Hold / 0 Sell, with average targets clustering around $670-$750.

🔮 Upcoming Catalysts (Next 6 Months)

Q2 2026 Earnings — Not Yet Confirmed, Estimated Early August (≈Aug 3-11)

This is the big near-term catalyst. Consensus of financial-data providers points to Axon reporting in early August, likely after market close (MarketBeat earnings calendar; MarketChameleon). Watch for ARR trajectory toward/above $1.6B, whether the 125% net revenue retention holds, another potential guidance raise, and any commentary on the ICE contract timeline.

ICE $220M TASER Contract Decision

With the incumbent contract lapsing August 21, a decision on the much larger $220M award is a genuine swing factor for the stock in either direction (CNBC).

Product Launches: Axon Vision & Axon Guardian

Axon Vision (enterprise/corrections computer vision) targets general availability in Q4 2026 (StockStory), and Axon Guardian (AI escalation-detection on body cameras) targets general availability in early Q4 2026 (Daily Political).

Mega-Event Counter-Drone Demand

2026's major U.S. gatherings (including the World Cup) are expected to drive Dedrone/counter-drone deployments, aided by the newly-passed Safer Skies Act, which adds $250M in federal drone-detection grants (Yahoo/Zacks).

---

🎲 Price Targets & Probabilities

Using the gamma structure, implied move, and the catalyst calendar through the September 18 expiration of today's trade:

📈 Bull Case (30% probability) — Target: $650-$733

A strong Q2 print (another guidance raise, ARR toward $1.6B) plus an actual ICE contract award would validate the recent run and push AXON toward the $600 gamma magnet and beyond, into the upper end of the September implied-move range ($733.32). This is the scenario where today's call seller looks early to sell.

🎯 Base Case (45% probability) — Target: $520-$600

AXON digests its recent 34%-in-a-week move, chops between the ≈$500 support pocket and the ≈$600 resistance magnet through the August earnings print, with the ICE decision still pending. This is the range where a covered-call overwrite or profit-take makes the most sense — collect premium/lock in gains while the stock consolidates.

📉 Bear Case (25% probability) — Target: $420-$500

A Q2 miss/guidance disappointment, an ICE contract loss or further delay, or simple mean-reversion after the sharp run could send AXON back toward the ≈$500 support pocket or lower, toward the $420 strike itself and the lower end of the implied-move range (≈$382.50). This is the scenario where today's call sale looks prescient.

---

👥 What Different Traders Should Take From This

🎲 YOLO Trader

This trade is a profit-taking/de-risking signal, not a bearish setup to chase. A YOLO play here would be betting on continued momentum toward the $600 gamma magnet ahead of August earnings using short-dated calls — but understand you'd be betting against the very flow that just printed, on a stock that's already up 34% in a week. High risk, and the person who sold today may know something about how extended this move is.

📈 Swing Trader

Watch the ≈$500 support pocket and ≈$600 resistance magnet as your range for the next few weeks. A pullback toward $500-$520 into the August earnings date, with the ICE contract still undecided, could offer a better risk/reward long entry than chasing at $557-571. If AXON breaks and holds above $600, that's confirmation the gamma ceiling has been absorbed.

💵 Premium Collector

This trade is basically a template for you. If you already own AXON shares from lower levels, selling calls against your position (a covered call) around the $600-$650 area for the September or October expiration collects real premium while AXON's stock has extended after a fast run — the same logic that may be behind today's $4.5M sale. Just be aware you'd cap upside if the ICE contract gets awarded and the stock rips further.

🌱 Beginner

Don't overthink this one: a deep-in-the-money call is basically a stock substitute, and selling it usually just means someone is cashing out or generating income — it is very different from someone buying puts to bet on a crash. The single most important lesson here is patience: we genuinely don't know yet if this was an open or a close. Wait for the next-day OI confirmation before drawing conclusions, and never assume a single options trade tells you where a stock is headed next.

---

⚠️ Risk Factors & Honest Limits

What today's tape can prove:

• ✅ The trade happened: 263 contracts, $420 strike calls, September 18 expiration, ≈$4.5M premium, executed at the bid on the regular lit market.
• ✅ It was a clean, single execution — no cancels, no multi-leg structure, no stock-combo pairing.

What today's tape CANNOT prove:

• ❌ Open vs. close. Size (263) ≈ prior OI (262) means this could be a fresh short position OR a close of an existing long — the tape alone can't distinguish them. This is the single biggest unknown in this article.
• ❌ Who did this or why, specifically. We can't see broker/MMID, customer identity, order ID, or whether the seller holds AXON shares (making this covered) or holds/held the long call itself (making this a close). We also can't see any hedge in the underlying stock or other option legs that may accompany this position.
• ❌ Whether this reflects a house view on AXON's fundamentals versus routine portfolio/risk management (position sizing, profit-taking discipline, tax planning, etc.).

Broader risks to be aware of:

• ⏰ Q2 earnings timing is not yet officially confirmed — the ≈early-August window is an estimate, and Axon could report earlier or later.
• 🎢 AXON is genuinely volatile and gamma is thin relative to mega-caps — moves can be sharper and less predictable than the gamma levels above suggest.
• 🏛️ The ICE $220M contract is not awarded — it's a headline-driven catalyst that could resolve bullish, bearish, or simply drag on without resolution.
• 📉 After a 44% three-month run, any disappointment at the August print carries outsized downside risk given how much good news is already priced in.

---

🎯 The Bottom Line

Real talk: Someone sold $4.5M worth of deep-in-the-money AXON calls at the bid, on a stock that's up ≈44% in three months and ≈34% in the past week. Next-day open interest has now confirmed the order type: this was a covered-call overwrite (STO — sold to open), not a profit-take — a fresh short-upside position, generating income on a big winner. It is still not a bearish bet against the company.

What we know:

• 🎯 A clean, single lit-market print — no games, no ambiguous structure.
• ✅ Order type CONFIRMED: STO. OI rose 262 → 530 (+268 vs. a 263-lot trade) — new contracts were created, so this opened a short call. Selling-to-close an old long (STC) is ruled out.
• 💰 Selling deep-ITM calls monetizes intrinsic value; it's a much lower-conviction bearish signal than buying puts would be.
• 📊 The $600 gamma level is the key resistance/magnet to watch; ≈$500 is the nearest real support pocket.

What we still don't know (and OPRA cannot tell us):

• 🏦 Whether the short call is genuinely covered — i.e. whether this desk owns the underlying AXON stock or deep long calls behind it. The overwrite read is an inference from the deep-ITM strike and the de-risking context, not a proven fact; a naked short call would look identical on the tape.
• ❓ The broker, the customer's identity, and any offsetting hedge sitting outside the OPRA option tape.

If you own AXON: Today's flow is a reasonable nudge to think about your own profit-taking discipline after a 34%-in-a-week move — consider whether a covered call into the August earnings print makes sense for your position, rather than assuming this trade is a signal to sell outright.

If you're watching from the sidelines: Wait for the August earnings date and the ICE contract resolution before chasing this move. A pullback toward the ≈$500 gamma support would offer a better entry than buying into an extended tape.

Mark your calendar:

• 📅 July 17 — Weekly OPEX (±7.6% implied move window closes)
• 📅 ≈Early August (Aug 3-11) — Q2 2026 earnings (estimated, not yet confirmed)
• 📅 August 21 — Incumbent ICE TASER contract lapses; decision window for the $220M award
• 📅 September 18 — Quarterly triple witch AND expiration of today's $4.5M call sale

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance doesn't guarantee future results. Always do your own research and consider consulting a licensed financial advisor before trading.

---

Last updated: July 14, 2026 — the next-day OPRA open-interest snapshot resolved the open/close flag. OI rose 262 → 530 (+268 vs. a 263-lot trade), confirming STO (sold to open) — a covered-call overwrite, not the profit-take (STC) alternative. The provisional ⏳ callout published on July 13 has been replaced with the ✅ RESOLVED box above; the "profit-taking or overwrite" framing has been narrowed to overwrite.

---

About Axon Enterprise: Axon Enterprise designs and sells the TASER conducted-energy device, body-worn and in-car cameras, and the Axon Evidence.com cloud-and-AI software platform (including Draft One, Axon Assistant, Fusus, and Dedrone) primarily to law enforcement, corrections, and enterprise security customers, with a market cap of ≈$43.0 billion in the Aerospace & Defense / Public-Safety Technology industry.